NOVEL COMPOSITION FOR MODULATING ISCHEMIC CELL DEATH

摘要

Described is the modulation of ischemic cell death. In particular, pharmaceutical compositions are provided comprising an inhibitor of p38 kinase and/or a nucleic acid molecule encoding said inhibitor which are particularly useful for treating, preventing and/or delaying ischemic cell death. Furthermore, methods for treating, preventing and/or delaying ischemic cell death comprising contacting organs, tissue or cells with an inhibitor of p38 kinase and/or a nucleic acid molecule encoding said inhibitor are described. In addition, methods and uses employing agents that activate p38 kinase for the treatment of tumors are provided.